Premium
Spotlight Commentary: How to prove pharmacology of immunomodulatory drugs in a phase 1 trial?
Author(s) -
Rissmann Robert,
Szabadi Elemer
Publication year - 2019
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13928
Subject(s) - tolerability , pharmacology , medicine , pharmacokinetics , pharmacodynamics , population , placebo , clinical trial , adverse effect , alternative medicine , pathology , environmental health